PMID: 16513038Mar 4, 2006Paper

Imaging studies and APOE genotype in persons at risk for Alzheimer's disease

Current Psychiatry Reports
Nikolaos Scarmeas, Yaakov Stern

Abstract

Many studies have investigated APOE-related differences in cerebral structure, blood flow, metabolism, and activation in an attempt to detect early brain changes in subjects at risk for Alzheimer's disease (AD). Structural magnetic resonance imaging studies have produced conflicting results, with some failing to detect APOE-related differences and others suggesting that epsilon4 carriers have more pronounced atrophy, particularly at medial temporal structures. All functional imaging studies done during rest in middle-aged and elderly subjects have found decreased cerebral metabolism for epsilon4 carriers (mostly in areas that usually are affected by AD), and some have reported faster cerebral metabolic reductions over time. Areas with decreased resting cerebral perfusion and metabolism, in addition to other areas with increased perfusion, have been reported in young epsilon4 carriers. Imaging studies done during the performance of various cognitive tasks in middle-aged and elderly subjects, and a single study in young subjects, have produced mixed results with regionally nonspecific increased, decreased, or nondifferential APOE-related activations depending on the cognitive task used. APOE-related findings in imaging studies of...Continue Reading

References

Oct 10, 1992·Lancet·F M van Bockxmeer, C D Mamotte
Nov 9, 1995·The New England Journal of Medicine·T PolvikoskiK Kontula
Mar 22, 1995·JAMA : the Journal of the American Medical Association·G W SmallL Chang
Sep 18, 1993·Lancet·S NoguchiN Yamada
Oct 1, 1998·Acta Neuropathologica·E GhebremedhinH Braak
Feb 9, 1999·Human Brain Mapping·D J MaddenR E Coleman
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·B Rypma, M D'Esposito
May 17, 2000·Proceedings of the National Academy of Sciences of the United States of America·G W SmallM E Phelps
Aug 17, 2000·The New England Journal of Medicine·S Y BookheimerG W Small
Aug 30, 2001·Proceedings of the National Academy of Sciences of the United States of America·M J de LeonJ Fowler
Dec 1, 2001·Pediatric Research·A TammiUNKNOWN STRIP project (Special Turku Coronary Risk Factor Intervention Project for children)
Jan 16, 2002·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Alison C BurggrenSusan Y Bookheimer
Jan 16, 2002·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Jeffrey R PetrellaP Murali Doraiswamy
Apr 24, 2002·Neurology·R J KillianyM S Albert
Oct 26, 2002·Science·Dennis J Selkoe
Dec 28, 2002·Diabetes·Stewart C FergusonBrian M Frier
Sep 25, 2003·JAMA : the Journal of the American Medical Association·Nikolaos ScarmeasKaren E Anderson
Dec 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Eric M ReimanJohn Hardy

❮ Previous
Next ❯

Citations

Jan 13, 2010·Archives of Neurology·Madhav ThambisettySusan M Resnick
Jul 16, 2010·Expert Review of Molecular Diagnostics·Thomas ZetzscheHarald Hampel
Jul 17, 2012·Biological Psychiatry·Madhav ThambisettySusan M Resnick
Dec 3, 2015·Brain Structure & Function·Junlin ShenChunshui Yu
Apr 2, 2016·Neural Plasticity·Maximilian WiesmannAmanda J Kiliaan
Sep 19, 2007·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Philip Shaw
Jun 7, 2014·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·Wenjun LiShi-Jiang Li
May 7, 2011·International Journal of Alzheimer's Disease·Meredith N BraskiePaul M Thompson
Apr 14, 2009·Topics in Magnetic Resonance Imaging : TMRI·Jean Théberge
Mar 1, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gwenn S SmithJovier D Evans
Dec 8, 2017·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Lance A JohnsonJacob Raber
Jul 26, 2015·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Karen RitchieNikolaos Scarmeas
Jan 25, 2020·Neurobiology of Disease·Elizabeth M RheaWilliam A Banks
Aug 21, 2018·Neuroscience and Biobehavioral Reviews·Gali H WeissbergerS Duke Han

❮ Previous
Next ❯

Related Feeds

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.